Using Duloxetine to prevent pancreatitis after ERCP procedures

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial evaluates the safety and efficacy of Duloxetine in preventing post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis, a common complication that can lead to serious health issues. The study involves administering Duloxetine or a placebo to patients who are undergoing ERCP for suspected pancreato-biliary disorders. Participants will be monitored for the occurrence of pancreatitis following the procedure, with the aim of determining whether Duloxetine can reduce the incidence of this complication.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age more than 18 years old.
* Gender: Males and Females
* Patients with suitable indications for ERCP due to suspected pancreato-biliary disorders.
* Blood amylase and lipase levels before ERCP are within the normal limits

Exclusion Criteria:

* Uncontrolled diabetes mellitus (DM)
* Severe bleeding tendency
* Impaired renal function (serum creatinine \> 2 mg/dL), (creatinine clearance \<30 ml/min)
* Patients with severe heart disease.
* Subjects who underwent prior biliary or pancreatic sphincterotomy or dilatation or stenting of either duct.
* Currently pregnant or nursing
* Admission due to established pancreatitis before ECRP
* Unwillingness to undergo ERCP.

Where it's running

• Tanta Unuversity
  Tanta, Egypt Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Improving evaluation and management of patients with suspected bile duct stones

  This study is testing a new way to improve how doctors check for and treat patients who might have stones in their bile duct.

  Recruiting University of Calgary · Calgary, Alberta · NCT05141916

• Registry for patients undergoing advanced endoscopy procedures

  This study is collecting information from adults who are having a special procedure called ERCP to help doctors understand how well it works for treating pancreatic and biliary diseases.

  Recruiting University of Calgary · Calgary, Alberta · NCT04259580

• Oral N-Acetylcysteine for Diabetic Macular Edema

  This study tests whether taking N-acetylcysteine by mouth can help people with center-involving diabetic macular edema who don’t yet need anti-VEGF therapy.

  Recruiting Phase 2 Tanta University · Damietta · NCT07917338

• 3D-Printed versus Conventional Palatal Cribs for Tongue Thrust in Children

  This study tests whether a 3D-printed cobalt-chromium palatal crib works better than a traditional soldered stainless steel crib to help kids stop tongue thrusting.

  Recruiting Tanta University · Tanta · NCT07895121

• Dia-Root Bio MTA vs MTA Plus forIndirect Pulp Capping in Young Permanent Molars

  This trial tests whether Dia-Root Bio MTA works as an indirect pulp cap in kids’ first permanent molars better or similar to standard MTA Plus.

  Recruiting Tanta University · Tanta · NCT07894523

• Nanohydroxyapatite vs Fluoride Varnish for MIH Front Teeth

  This trial tests whether a nanohydroxyapatite varnish can remineralize MIH-affected front teeth in 8–11 year-olds as effectively as a standard 5% fluoride varnish.

  Recruiting Tanta University · Tanta · NCT07894510

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.